Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1974 Sep;11(3):249–252. doi: 10.1136/jmg.11.3.249

Cystic fibrosis: current concepts.

M J Polley, A G Bearn
PMCID: PMC1013136  PMID: 4139260

Full text

PDF
249

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnett D. R., Kurosky A., Bowman B. H., Hutchison H. T., Schmoyer I., Carson S. D. Cystic fibrosis: molecular weight estimation of the ciliary inhibitor. Tex Rep Biol Med. 1973 Winter;31(4):703–708. [PubMed] [Google Scholar]
  2. Bearn A. G. Cell culture in inherited disease--with some notes on genetic heterogeneity. N Engl J Med. 1972 Apr 6;286(14):764–767. doi: 10.1056/NEJM197204062861409. [DOI] [PubMed] [Google Scholar]
  3. Bearn A. G., Danes B. S. A genetic study of cystic fibrosis of the pancreas in cell culture. Trans Assoc Am Physicians. 1969;82:248–252. [PubMed] [Google Scholar]
  4. Berggård I., Bearn A. G. Isolation and properties of a low molecular weight beta-2-globulin occurring in human biological fluids. J Biol Chem. 1968 Aug 10;243(15):4095–4103. [PubMed] [Google Scholar]
  5. Besley G. T., Patrick A. D., Norman A. P. Inhibition of the motility of gill cilia of Dreissensia by plasma of cystic fibrosis patients and their parents. J Med Genet. 1969 Sep;6(3):278–280. doi: 10.1136/jmg.6.3.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Biggar W. D., Holmes B., Good R. A. Opsonic defect in patients with cystic fibrosis of the pancreas. Proc Natl Acad Sci U S A. 1971 Aug;68(8):1716–1719. doi: 10.1073/pnas.68.8.1716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bokisch V. A., Müller-Eberhard H. J. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J Clin Invest. 1970 Dec;49(12):2427–2436. doi: 10.1172/JCI106462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bowman B. H., Barnett D. R., Matalon R., Danes B. S., Bearn A. G. Cystic fibrosis: fractionation of fibroblast media demonstrating ciliary inhibition. Proc Natl Acad Sci U S A. 1973 Feb;70(2):548–551. doi: 10.1073/pnas.70.2.548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bowman B. H., Hirschhorn K., Bearn A. G. Letter: Bioassays of cystic-fibrosis factor. Lancet. 1974 Mar 9;1(7854):404–405. doi: 10.1016/s0140-6736(74)93166-3. [DOI] [PubMed] [Google Scholar]
  10. Bowman B. H., Lockhart L. H., McCombs M. L. Oyster ciliary inhibition by cystic fibrosis factor. Science. 1969 Apr 18;164(3877):325–326. doi: 10.1126/science.164.3877.325. [DOI] [PubMed] [Google Scholar]
  11. Bowman B. H., McCombs M. L., Lockhart L. H. Cystic fibrosis: characterization of the inhibitor to ciliary action in oyster gills. Science. 1970 Feb 6;167(3919):871–873. doi: 10.1126/science.167.3919.871. [DOI] [PubMed] [Google Scholar]
  12. Conover J. H., Conod E. J., Hirschhorn K. Ciliary-dyskinesia factor in immunological and pulmonary disease. Lancet. 1973 May 26;1(7813):1194–1194. doi: 10.1016/s0140-6736(73)91205-1. [DOI] [PubMed] [Google Scholar]
  13. Conover J. H., Conod E. J., Hirschhorn K. Letter: Complement components in cystic fibrosis. Lancet. 1973 Dec 29;2(7844):1501–1501. doi: 10.1016/s0140-6736(73)92768-2. [DOI] [PubMed] [Google Scholar]
  14. Conover J. H., Conod E. J., Hirschhorn K. Serum-hexosaminidase levels in cystic fibrosis. Lancet. 1973 May 19;1(7812):1122–1122. doi: 10.1016/s0140-6736(73)90432-7. [DOI] [PubMed] [Google Scholar]
  15. Danes B. S. Association of cystic-fibrosis factor to metachromasia of the cultured cystic-fibrosis fibroblast. Lancet. 1973 Oct 6;2(7832):765–767. doi: 10.1016/s0140-6736(73)91041-6. [DOI] [PubMed] [Google Scholar]
  16. Danes B. S., Bearn A. G. Cystic fibrosis of the pancreas. A study in cell culture. J Exp Med. 1969 Apr 1;129(4):775–793. doi: 10.1084/jem.129.4.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Danes B. S., Bearn A. G. Oyster ciliary inhibition by cystic fibrosis culture medium. J Exp Med. 1972 Nov 1;136(5):1313–1317. doi: 10.1084/jem.136.5.1313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Danes B. S., Flensborg E. W. Cystic fibrosis: cell culture studies on a Danish population. Am J Hum Genet. 1971 May;23(3):297–302. [PMC free article] [PubMed] [Google Scholar]
  19. Danes B. S., Litwin S. D., Hütteroth T. H., Cleve H., Bearn A. G. Characterization of cystic fibrosis factor and its interaction with human immunoglobulin. J Exp Med. 1973 Jun 1;137(6):1538–1543. doi: 10.1084/jem.137.6.1538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Houck J. C., Sharma V. K. Functional failures of "fibrocystic" fibroblasts. Proc Soc Exp Biol Med. 1970 Nov;135(2):369–372. doi: 10.3181/00379727-135-35053. [DOI] [PubMed] [Google Scholar]
  21. Pallavicini J. C., Wiesmann U., Uhlendorf W. B., Di Sant' Agnese P. A. Glycogen content of tissue culture fibroblasts from patients with cystic fibrosis and other heritable disorders. J Pediatr. 1970 Aug;77(2):280–284. doi: 10.1016/s0022-3476(70)80336-5. [DOI] [PubMed] [Google Scholar]
  22. Rennert O. M., Julius R. L., LaPointe D. RNA methylation, a possible genetic marker in cystic fibrosis. Pediatrics. 1972 Sep;50(3):485–487. [PubMed] [Google Scholar]
  23. South M. A., Warwick W. J., Wolheim F. A., Good R. A. The IgA system. 3. IgA levels in the serum and saliva of pediatric patients--evidence for a local immunological system. J Pediatr. 1967 Nov;71(5):645–653. doi: 10.1016/s0022-3476(67)80199-9. [DOI] [PubMed] [Google Scholar]
  24. Spock A., Heick H. M., Cress H., Logan W. S. Abnormal serum factor in patients with cystic fibrosis of the pancreas. Pediatr Res. 1967 May;1(3):173–177. doi: 10.1203/00006450-196705000-00003. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES